Digoxin in atrial fibrillation: Report from the Stockholm Cohort study of Atrial Fibrillation (SCAF)

Heart

Volumn 96, Issue 4, 2010, Pages 275-280

  Friberg, L ^a   Hammar, N ^b,c   Rosenqvist, M ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOLOGY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DEATH; DIAGNOSIS; FEMALE; GERIATRICS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DIGOXIN; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77649086488     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.175786     Document Type: Article

References (17)

1. Eichhorn EJ, Gheorghiade M. Digoxin-new perspective on an old drug. N Engl J Med 2002;347:1394-5.
2. Lewis T. Clinical disorders of the heartbeat. A handbook for practitioners and students. New York: Hoeber, 1910. http://www.archive.org/ details/clinicaldisorder00lewiuoft (accessed 29 October 2009).
3. Jaeschke R, Oxman AD, Guyatt GH. To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and metaanalysis. Am J Med 1990;88:279-86.
4. Roberts SA, Diaz C, Nolan PE, et al. Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. Am J Cardiol 1993;72:567-73.
5. Garg R, Gorlin R, Smith T, et al. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997;336:525-33.
6. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13.
7. Hallberg P, Lindback J, Lindahl B, et al. Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol 2007;63:959-71.
8. Friberg L, Hammar N, Ringh M, et al. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study of Atrial Fibrillation (SCAF). Eur Heart J 2006;27:1954-64.
9. Friberg L, Hammar N, Pettersson H, et al. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-study of Atrial Fibrillation (SCAF). Eur Heart J 2007;28:2346-53.
10. Friberg L, Hammar N, Rosenqvist M. Incidence of stroke in paroxysmal atrial fibrillation - report from the Stockholm Cohort of Atrial Fibrillation (SCAF). Eur Heart J doi:10.1093/eurheartj/ehn599.
11. Groenwold RH, Hak E, Hoes AW. Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies. J Clin Epidemiol 2009;62:22-8.
12. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745.
13. Hammar N, Alfredsson L, Rosen M, et al. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001;30(Suppl 1):S30-4.
14. Lindblad U, Råstam L, Ranstam J, et al. Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 1993;21:3-9.
15. Stegmayr B, Asplund K. Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology 1992;11:204-13.
16. Wilhelmsen L, Rosengren A, Eriksson H, et al. Heart failure in the general population of men-morbidity, risk factors and prognosis. J Intern Med 2001;249:253-61.
17. Schaufelberger M, Swedberg K, Koster M, et al. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 2004;25:300-7.